Fulda, March 02, 2026
meddevo GmbH announces an expansion of its shareholder structure. Effective February 19, 2026, B2MAS Holding GmbH, solely owned by Dr. Bassil Akra, entered into a shareholder agreement with meddevo’s founders, Michael Kania and Matthias Risto.
Dr. Bassil Akra is internationally recognized as a leading authority in medical device and in vitro diagnostic regulation. His expertise spans research and development, manufacturing, testing, conformity assessment, scientific research, and international standards development.
His entry represents a strategic partnership. meddevo remains fully independent private entity and continues to pursue its long term and self financed growth strategy.
Since the start of product development in 2017 and market entry in 2018, meddevo has grown organically and independently. All revenues have been consistently reinvested into product development, team expansion, and regulatory innovation.
The company plans to build on this foundation by increasing its total investments in product development, international expansion and technological innovation. Those investments will keep customer expectations and needs in the focus by delivering continuous value-add and maintaining product excellence.
Today, meddevo is recognized as a leading SaaS provider for the digitalization of technical documentation and regulatory processes in the MedTech industry. With Dr. Akra joining, the company will further accelerate its international expansion and recognition.
Several major product innovations are scheduled for the next 3 Years. These include innovative new electronic IFU, Declaration of Conformity, and Digital Label formats designed to replace outdated formats. This will significantly enhance end user experience and ensure compliance with the newest state of the art expectations.
“We deliberately chose not to pursue Venture Capital because our goal is to build sustainable regulatory solutions, not short term valuation targets,” said Michael Kania, Founder and CEO of meddevo. “Our focus remains on product quality, regulatory depth, and long term customer success. With Dr. Bassil Akra, we are gaining a strategic partner who shares this vision.”
Dr. Bassil Akra added, “meddevo combines deep regulatory expertise with advanced technology and a clear long term mindset. I am pleased to support the company and contribute to its continued international growth.”
There will be no changes to meddevo’s management team, operational structure, client contracts, or day to day customer interactions. With its expanded shareholder structure, meddevo reinforces its commitment to remain an independent Regulatory Tech partner, setting sustainable digital standards for the future of the MedTech industry.
About Us
meddevo GmbH is a SaaS company which provides solutions for medtech Professionals, like meddevo eTD and meddevo eIFU.
Unlike traditional systems that focus only on storing documents, meddevo uses a data-driven approach: all important product and compliance information are managed as structured data in a unique eTD data model. This allows users to automate documents and digitalize regulatory processes, ensuring consistency and saving time.
meddevo GmbH, Frankfurter Str. 15 , 36043 - Fulda
Mail: contact@meddevo.com